222 related articles for article (PubMed ID: 37489549)
1. Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.
Raetz EA; Bhojwani D; Devidas M; Gore L; Rabin KR; Tasian SK; Teachey DT; Loh ML
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30585. PubMed ID: 37489549
[TBL] [Abstract][Full Text] [Related]
2. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system-directed therapy in the treatment of childhood acute lymphoblastic leukemia and studies of neurobehavioral outcome: Children's Cancer Group trials.
Kaleita TA
Curr Oncol Rep; 2002 Mar; 4(2):131-41. PubMed ID: 11822985
[TBL] [Abstract][Full Text] [Related]
4. Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.
Hunger SP; Loh ML; Whitlock JA; Winick NJ; Carroll WL; Devidas M; Raetz EA;
Pediatr Blood Cancer; 2013 Jun; 60(6):957-63. PubMed ID: 23255467
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital.
Rivera GK; Pinkel D; Simone JV; Hancock ML; Crist WM
N Engl J Med; 1993 Oct; 329(18):1289-95. PubMed ID: 8413409
[TBL] [Abstract][Full Text] [Related]
8. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract][Full Text] [Related]
9. Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M; Manabe A
Pediatr Int; 2018 Jan; 60(1):4-12. PubMed ID: 29143423
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of two consecutive trials in childhood acute lymphoblastic leukaemia performed by the Spanish Cooperative Group for Childhood Acute Lymphoblastic Leukemia Group (SHOP) from 1989 to 1998.
Badell I; Muñoz A; Estella J; Fernández-Delgado R; Javier G; Verdeguer A; Cubells J;
Clin Transl Oncol; 2008 Feb; 10(2):117-24. PubMed ID: 18258511
[TBL] [Abstract][Full Text] [Related]
11. Childhood and adolescent lymphoid and myeloid leukemia.
Pui CH; Schrappe M; Ribeiro RC; Niemeyer CM
Hematology Am Soc Hematol Educ Program; 2004; ():118-45. PubMed ID: 15561680
[TBL] [Abstract][Full Text] [Related]
12. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
13. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].
Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM
Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717
[No Abstract] [Full Text] [Related]
14. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.
Bowman WP; Larsen EL; Devidas M; Linda SB; Blach L; Carroll AJ; Carroll WL; Pullen DJ; Shuster J; Willman CL; Winick N; Camitta BM; Hunger SP; Borowitz MJ
Pediatr Blood Cancer; 2011 Oct; 57(4):569-77. PubMed ID: 21360654
[TBL] [Abstract][Full Text] [Related]
15. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
[TBL] [Abstract][Full Text] [Related]
16. Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Gupta S; Teachey DT; Chen Z; Rabin KR; Dunsmore KP; Larsen EC; Maloney KW; Mattano LA; Winter SS; Carroll AJ; Heerema NA; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Winick NJ; Loh ML; Hunger SP; Devidas M
Cancer; 2022 May; 128(9):1863-1870. PubMed ID: 35201611
[TBL] [Abstract][Full Text] [Related]
17. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
18. Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2.
Hastings C; Chen Y; Devidas M; Ritchey AK; Winick NJ; Carroll WL; Hunger SP; Wood BL; Marcus RB; Barredo JC
Pediatr Blood Cancer; 2021 Dec; 68(12):e29256. PubMed ID: 34302704
[TBL] [Abstract][Full Text] [Related]
19. An odyssey in search of a cure: the evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom.
Saha V; Eden T
Indian J Pediatr; 1993; 60(4):525-38. PubMed ID: 8262589
[TBL] [Abstract][Full Text] [Related]
20. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.
Pui CH; Sandlund JT; Pei D; Campana D; Rivera GK; Ribeiro RC; Rubnitz JE; Razzouk BI; Howard SC; Hudson MM; Cheng C; Kun LE; Raimondi SC; Behm FG; Downing JR; Relling MV; Evans WE;
Blood; 2004 Nov; 104(9):2690-6. PubMed ID: 15251979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
